8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) January 12, 2009

ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC.

(Exact name of registrant as specified in its charter)

Delaware	000-32085	36-4392754
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)

222 Merchandise Mart, Suite 2024

Chicago, IL 60654

Registrant’s telephone number, including area code 1-866-358-6869

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

ITEM 7.01. Regulation FD Disclosure.

Attached as Exhibit 99.1 hereto is an Investor Presentation dated January 2009, which is incorporated herein by reference.

This information is being furnished pursuant to Item 9 of this Report and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section and will not be incorporated by reference into any registration statement filed by Allscripts Healthcare Solutions, Inc. under the Securities Act of 1933, as amended, unless specifically identified as being incorporated therein by reference. This Report will not be deemed an admission as to the materiality of any information in this Report that is being disclosed pursuant to Regulation FD.

Please refer to page 2 of Exhibit 99.1 for a discussion of certain forward-looking statements included therein and the risks and uncertainties related thereto.

ITEM 9.01. Financial Statements, Pro Forma Financial Information and Exhibits.

(d) Exhibits:

99.1 Investor Presentation dated January 2009

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	ALLSCRIPTS-MISYS HEALTHCARE SOLUTIONS, INC.
Date: January 12, 2009	By:	/s/ William J. Davis
		William J. Davis Chief Financial Officer

3

EXHIBIT INDEX

The following exhibits are filed herewith:

Exhibit No.
99.1	Investor Presentation dated January 2009.

EX-99.1

Connect to Health™

Allscripts Investor Presentation –

January 2009

EXHIBIT 99.1

2

Forward Looking Statements

This

communication

contains

forward-looking

statements

within

the

meaning

of

the

federal

securities

laws.

Statements

regarding

future

events,

developments,

the

Company’s

future

performance,

as

well

as

management’s

expectations,

beliefs,

intentions,

plans,

estimates

or

projections

relating

to

the

future

are

forward-

looking

statements

within

the

meaning

of

these

laws.

These

forward-looking

statements

are

subject

to

a

number

of

risks

and

uncertainties,

some

of

which

are

outlined

below.

As

a

result,

actual

results

may

vary

materially

from

those

anticipated

by

the

forward-looking

statements.

Among

the

important

factors

that

could

cause

actual

results

to

differ

materially

from

those

indicated

by

such

forward-looking

statements

are:

the

volume

and

timing

of

systems

sales

and

installations;

length

of

sales

cycles

and

the

installation

process;

the

possibility

that

products

will

not

achieve

or

sustain

market

acceptance;

the

timing,

cost

and

success

or

failure

of

new

product

and

service

introductions,

development

and

product

upgrade

releases;

competitive

pressures

including

product

offerings,

pricing

and

promotional

activities;

our

ability

to

establish

and

maintain

strategic

relationships;

undetected

errors

or

similar

problems

in

our

software

products;

compliance

with

existing

laws,

regulations

and

industry

initiatives

and

future

changes

in

laws

or

regulations

in

the

healthcare

industry;

possible

regulation

of

the

Company’s

software

by

the

U.S.

Food

and

Drug

Administration;

the

possibility

of

product-related

liabilities;

our

ability

to

attract

and

retain

qualified

personnel;

our

ability

to

identify

and

complete

acquisitions,

manage

our

growth

and

integrate

acquisitions;

the

ability

to

recognize

the

benefits

of

the

merger

with

Misys

Healthcare

Systems,

LLC

(“MHS”);

the

integration

of

MHS

with

the

Company

and

the

possible

disruption

of

current

plans

and

operations

as

a

result

thereof;

maintaining

our

intellectual

property

rights

and

litigation

involving

intellectual

property

rights;

risks

related

to

third-party

suppliers;

our

ability

to

obtain,

use

or

successfully

integrate

third-party

licensed

technology;

breach

of

our

security

by

third

parties;

and

the

risk

factors

detailed

from

time

to

time

in

our

reports

filed

with

the

Securities

and

Exchange

Commission,

including

our

2007

Annual

Report

on

Form

10-K

available

through

the

Web

site

maintained

by

the

Securities

and

Exchange

Commission

at

www.sec.gov.

The

Company

undertakes

no

obligation

to

update

publicly

any

forward-looking

statement,

whether

as

a

result

of

new

information,

future

events

or

otherwise.

3

The Story…

There is Now a Clear Market Leader…

-

150,000 Physicians

-

700 Hospitals

-

Top-Rated

in

All

Product

Categories

…

that is Strong and Stable

-

Revenue ~ $700mm

-

Electronic Health Records ~ $200mm

-

Revenue Cycle Management (Practice Management + Claims

Processing) ~ $400mm

-

Health System Solutions ~ $100mm

-

Recurring Revenue ~ $400mm

…

in a Growing Market

-

Market Size ~ $10b

-

Growth ~ 15-20% in EHR markets

1

2008 Year-End KLAS Report

1

4

Why Allscripts + Misys?

›

Brought two market leaders together

›

110,000 + 40,000

›

Perfectly positioned to win in a vibrant,

growing market with a $10B market

opportunity

–

Electronic Health Record

–

Revenue Cycle Management

›

~$1B cross-sell

opportunity within base

›

$20+M in cost synergies

5

2001:

Form Partnership to Bring Allscripts EHR

to IDX PM Base

Install

Base

(2001)

=

138,000

MDs Primarily

in Larger Practices

A Proven Approach

Install Base (2008) = 110,000

MDs Primarily in

Small-Mid Sized Practices

2008:

Allscripts and Misys Come Together

Bringing EHR to Misys PM Base

Practice Management System

Electronic Health Record

6

The Time is Now…

7

Practice Automation is Critical to the Fix…

›

Increases the Quality of Care

›

Takes Costs Out

›

Increase Reimbursement

›

Improves Patient Safety

›

Increases Patient Satisfaction

8

The Path is Clear…

“We're investing in electronic medical records

and other technologies that can drive down

healthcare costs.”

-

President-elect Barack Obama

“Cost savings from a mandatory requirement

that Medicare providers adopt and use HIT as

a condition of participating in the Medicare

program…savings total $34 billion over 10

years

from physicians and hospitals

.”

-

CBO

1

Congressional Budget Office –

12/08 –

Budget Options Vol. I –

Health Care

1

9

Key Trends Driving Technology Adoption Now

›

Declining Reimbursement for Physicians

›

Incentives for Technology Adoption

-

ePrescribing CMS Incentive ~ $3,000 to $4,000 per MD/year

-

PQRI Incentive ~ $3,000 to $4,000 per MD/year

-

Stark Safe Harbor Enables Hospitals to Fund up to 85% of EHR

and up to 100% of ePrecribing

›

EHRs

Increasingly Seen as a “Standard of Practice”

›

Patients Are Not Patient Anymore

10

›

< 20% Physician

Penetration

›

< 10% in Smaller

Groups

The Opportunity is Significant

The Electronic

Health Record

Revenue Cycle

Management

›

~10% to 20% of PM

Systems Replaced/Yr.

›

Allscripts 3

Largest

Claims Processing

Clearinghouse

+

Significant

Upside

›

Lower IT

Penetration than

Any Sector of

Economy

=

All Results in a $10+ Billion Market Opportunity

rd

11

A Great Place to Start…Our Client Base

›

150,000 MDs

and

700+ Hospitals

Across the U.S.

›

90,000 MDs

without

an EHR

›

~ $1B

Cross-Sell

Opportunity

12

12

Professional EHR + PM

EDI

~40% penetration

1.3k practices

65k physicians

Enterprise EHR + PM

EDI

~10% penetration

170k practices

241k physicians

Professional EHR + PM

ASP-Based EHR

EDI

Segment

Allscripts Offering

Penetration/Size

~20% penetration

33k practices

227k physicians

Independent

Practices

1-3 physicians

Leadership Across the Ambulatory Market

Small to Mid-Sized

Physician Practices

4-25 Physicians

Large Physician

Practices

26-200+ Physicians

13

Connect Solutions

•

Connect Portal

•

Connect Messaging Services

Community Care

……

……

Clinical Solutions

•

Professional EHR

•

Enterprise EHR

•

MyWay

•

ePrescribe

•

Document Management

•

Medication Services

•

Clinical Trials

•

Patient Access Solutions

Business Solutions

•

PM/ Revenue Cycle Services

•

Payerpath / EDI

Ambulatory

Care

Emergency Department

Care Management

•

Utilization Management

•

Discharge Planning

•

Documentation Integrity

•

Quality Management

Stark Offerings

•

EHR Solutions

•

ePrescribe

Acute

Care

Homecare

•

Home Health & Private Duty

•

Hospice

Referral Management

•

Referral Management Plus

•

Mobile

•

Core System Integration

Post-Acute

Care

A Diversified Portfolio

14

Our Operating Leaders…

Vern Davenport

President

Clients:

21,000+ clients

Small to mid-sized practices

Employees:

~1,700 employees

160 sales reps (30 inside)

Laurie McGraw

President

Clients:

5,000 clients

Large Physicians Practices,

IDNs, and Hospitals

Employees:

~350 employees

35 sales reps (9 inside)

Jeff Surges

President

Clients:

700 hospitals

6,000 post-acute providers

600+ homecare and hospice

agencies

Employees:

~300 employees

35 sales reps (5 inside)

Professional

Solutions

Enterprise

Solutions

Health Systems

Group

15

15

Waves of Healthcare IT Adoption

Electronic          

Health Record

Market

Enhance the efficiency and

quality of the visit

Wave

2

Allscripts Leadership in EHR

Product and Blue Chip

Client Base

Practice

Management

Market

Enhance the

effectiveness of the

practice

Wave

1

Misys Leadership in Building

Practice Management / Claims

Management Client Base

Connectivity

and

Information

Market

Enhance the health of the

patient and the practices

bottom line

Wave

3

AllscriptsMisys Leadership in

New Solutions and Services

16

Bloomberg of Healthcare

The Real Power Comes When You Connect

17

The Allscripts Equation

Market Growth/Expansion Opportunity

+

Market Leadership

+  Innovation

+  Financial Stability

=  Strongest Player in an Expanding Market

18

Financial Overview

*

*

*

*

*

*

19

2009 Outlook

($ in millions - unaudited pro forma)

Fiscal

Fiscal

Guidance

2008

2009

Bookings

$317.7

N/A

Revenue

$684.2

$700.0 to $715.0

Less: PI

(15.0)

0.0

Adjusted Revenue

$669.2

$700.0 to $715.0

Non-GAAP Net Income

$62.6

$76.0 to $82.0

Less: Physicians Interactive

(1.1)

0.0

Less: Synergies Timing

0.0

0.0

Less: Amortization Timing

0.0

0.0

Non-GAAP Net Income

$61.5

$76.0 to $82.0

Non-GAAP Net Income Per Share

$0.43

$0.49 to $0.53

Pro Forma Share Count

148.0

154.0

Note: Fiscal 2008 reflects actual results for Misys Healthcare (under U.S GAAP) for the year ended May 31, 2008

    and the trailing 12-months for Allscripts for the period ended June 30, 2008.

Note 2: Adjusted earnings is a non-GAAP financial measure. See reconciliation to comparable GAAP

    measure on page 24.

20

Non-GAAP Net Income Potential

($ in millions - unaudited pro forma)

Fiscal

Fiscal

2008

2009

Earnings Before Taxes, as reported

$57.5

$96.0 to $106.0

Taxes (Assumed @ 40% in 09 and 39% in 08)

(22.4)

($38.0 to $45.0)

Net Income

$35.1

$58.0 to $64.0

Adjustments: (tax adjusted @ 40% in 09 and 39% in 08)

Stock-Based Compensation

$5.4

$6.6

Deal-Related Amortization

14.0

11.4

One-Time Costs / Transaction Related Expenses

8.1

-

Physicians Interactive

(1.1)

-

Total Adjustments

$26.4

$18.0

Non-GAAP Net Income

$61.5

$76.0 to $82.0

Non-GAAP Net Income Growth

42%

24% to 33%

21

Illustrative Revenue Sensitivity Analysis

Four Year Cumulative Penetration Rates

110,000

MDs

20%

Assumed EHR Penetration

88,000

Addressable EHR Market

20%

30%

40%

50%

60%

License/Service Fees

$165m

$248m

$330m

$410m

$495m

Annual Maintenance

$20m

$30m

$40m

$50m

$60m

22

Significant and Realizable Synergy Opportunity

›

Cost synergies of $20m+, pre-tax,

expected in first year following

transaction close

-

Up to $25m to $30m, pre-tax, in annual

cost savings within the next few years

-

Main drivers of cost synergies include:

R&D, Marketing, Sales, Administrative

Functions

›

Revenue synergies from cross-selling

into respective client bases is expected

to be ~$7m+ in FY 2009

›

Increased operating leverage expected

to result in mid teens EPS growth

Projected Cost Synergies

$20m+

$25 -

$30m

First Year

Run Rate

23

Capital Structure

(shares in millions)

Ownership %

Allscripts Outstanding Shares

63.0

41.4%

Allscripts Shares Issued to Misys plc

82.9

54.5%

Shares Underlying Remaining Debentures

2.5

2.3%

"In the Money" Options

2.4

1.5%

Unvested Restricted Stock Units

0.4

0.2%

Outstanding Equity as of Closing

151.1

100.0%

Estimated Number of RSU Grants in FY 2009

4.0 to 4.5

24

Summary

a complete portfolio

of solutions…

for practices in all sizes/areas…

a footprint of 1 of 3 MDs

in the U.S.

Products

Target

Client Base